Vetscan Imagyst Unveils New AI Masses Technology for Faster Cancer Detection in Veterinary Clinics

Zoetis Inc., the world’s leading animal health company, has today announced a new Vetscan Imagyst capability, AI Masses, which uses best-in-class AI to analyze potentially neoplastic cells in lymph node and subcutaneous lesions. This addition offers veterinary health teams the ability to make more informed treatment decisions, improve clinic efficiency, elevate pet owners’ experience and expand access to care for pets.